| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5603720 | Indian Heart Journal | 2016 | 5 Pages |
Abstract
Heparin infusion maintains a steady target ACT level and avoids peaks and troughs associated with bolus doses. Lower level of anticoagulation using continuous heparin infusion does not increase ischemic complications. This is the first ever study of use of heparin infusion during OPCAB. We may conclude that heparin infusion is a safe anticoagulation strategy for OPCAB.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kamales Kumar Saha, Dinesh Kumar Sangwan, Pravin K. Shroff, Mandar Manohar Deval, Kakalee K. Saha, Rinu V. Jacob, Ratnaprobha Adsul, Lukash Jagdale,